To further confirm whether CBP and RFPL-3 activated hTERT transcription, CBP-specific siRNA or RFPL-3-specific siRNA was used to knock down CBP or RFPL-3 expression, respectively, in SKBR-3 and MDA-MB-231 breast cancer cells. Here, RFPL3 is linked to breast carcinoma.